Pilot Randomised Controlled Trial of ToQuit Intervention in India
ToQuit
1 other identifier
interventional
100
1 country
1
Brief Summary
Tobacco use is associated with high mortality, and a range of morbidities including cancer, and lung and cardiovascular diseases. Furthermore, tobacco users who die prematurely deprive their families of income, raise the cost of health care and hinder economic development. India is the second-largest consumer (current use-48% males, 20% females; 275 million adults) and third largest producer of tobacco in the world5; and has one of the highest mortality related to tobacco. The treatment gap for tobacco use in India is as high as 92%. Opportunistic screening and brief interventions in primary care, although recommended by the World Health Organization (WHO), is largely missing in current practice in India. The existing tobacco cessation strategy in India has shown limited success due to poor availability and accessibility of tobacco cessation services, and non-availability of interventions that are culturally relevant and contextual to the target population. Preliminary formative research as a part of the larger ToQuit study has informed the development of the first version of the treatment package. This first version of the package was tested through a case series, by refining the intervention content and delivery mechanisms through an iterative process, to develop the final intervention. This pilot Randomised Control Trial (RCT) will aim to empirically evaluate the feasibility and acceptability of the mobile-based brief intervention (BI) for tobacco use, generate preliminary estimates of the impact of the BI, and fine-tune the procedures for a definitive RCT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedStudy Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2021
CompletedSeptember 21, 2021
September 1, 2021
6 months
February 19, 2021
September 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-reported abstinence from tobacco in past 7 days preceding the outcome assessment
After 3 months post-randomisation, all the participants will be asked if they used tobacco at least once in past 7 days.
At 3 months post-randomisation in all participants regardless of treatment completion.
Secondary Outcomes (2)
Change in mean ASSIST score, from baseline to 3 months post-randomisation
At baseline and at 3 months post-randomisation in all participants regardless of treatment completion.
Self-reported abstinence from tobacco in past 28 days preceding the outcome assessment
At 3 months post-randomisation in all participants regardless of treatment completion.
Study Arms (2)
ToQuit
EXPERIMENTALParticipants from the ToQuit intervention arm will receive the messages on their mobile phones for 8 weeks. The messages will be sent for 3-4 days a week.
Control
OTHERParticipants from the control group will be sent the details of other functional tobacco helplines in India.
Interventions
The intervention messages will consist of specific content areas derived from the formative research of the study. Some of the components of the intervention include * Psychoeducation about consequences of tobacco use and benefits of quitting; * goal setting; * managing goals and self-monitoring of behavior; * avoidance strategies; * self-awareness and reflection messages; * social and pharmacological support, and help-seeking; * identifying and managing cravings; * relapse prevention strategies.
Participants from the control group will be sent the details of other functional tobacco helplines in India.
Eligibility Criteria
You may qualify if:
- Adult (\>18 years) current users of tobacco in any form. Current user will be defined as individuals who have used tobacco at least once in the past 28 days.
- Willing to quit tobacco in next 2 months,
- Having a personal mobile phone, and
- Able to read and reply to short message service (SMS) text in English or Hindi
You may not qualify if:
- Participants having a shared/family phone
- Age \<18 years
- Owns a mobile phone, but cannot read and reply to English or Hindi messages
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sangathlead
Study Sites (1)
Sangath Goa
Panjim, Goa, 403501, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abhijit Nadkarni
London School of Hygiene and Tropical Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The PI and outcomes assessor will be masked. The screeners will recruit participants into the study, who will then be randomized to one of the two study arms. The data team will assign a masked outcome assessor to collect outcome data.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 19, 2021
First Posted
March 4, 2021
Study Start
April 1, 2021
Primary Completion
September 18, 2021
Study Completion
September 18, 2021
Last Updated
September 21, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share